ConductScience.org, home

Paper41001838

Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer.

Li X and 2 others. J Cell Mol Med, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer. Papers, record 41001838. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41001838

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer.
PubMed
Journal
J Cell Mol Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li XXinwei
2Meng YYue
3Gu BBinghttps://orcid.org/0000-0001-7764-3213

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Biomarkers, TumorMajor topic
Humans
Female
Gene Expression Regulation, Neoplastic
Prognosis
DNA Methylation
Cell Proliferation
Computational Biology
Promoter Regions, Genetic
Apoptosis
Cell Line, Tumor
Gene Expression Profiling

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82003149the National Natural Science Foundation of ChinaPubMed
KY012023289The Research Foundation for Advanced Talents of Guangdong Provincial People's HospitalPubMed
2025A1515010446Natural Science Foundation of Guangdong Province, ChinaPubMed
2023B110008Guangdong Provincial Clinical Research Center for Laboratory MedicinePubMed

Source PubMed

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140351118CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance.Oncoimmunology2025https://conductscience.org/library/papers/40351118PubMed
211709054Mechanisms of p53-dependent apoptosis.Biochem Soc Trans2001https://conductscience.org/library/papers/11709054PubMed
338571942Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy.Front Immunol2024https://conductscience.org/library/papers/38571942PubMed
433538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
525652405The 3' addition of CCA to mitochondrial tRNASer(AGY) is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase TRNT1.Hum Mol Genet2015https://conductscience.org/library/papers/25652405PubMed
610228556Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.Cell Mol Life Sci1999https://conductscience.org/library/papers/10228556PubMed
731342438The Implication of mRNA Degradation Disorders on Human DISease: Focus on DIS3 and DIS3-Like Enzymes.Adv Exp Med Biol2019https://conductscience.org/library/papers/31342438PubMed
834159625Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer.J Gastroenterol Hepatol2021https://conductscience.org/library/papers/34159625PubMed
939329702Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer.Cells2024https://conductscience.org/library/papers/39329702PubMed
1039456618The Diversity of Methylation Patterns in Serous Borderline Ovarian Tumors and Serous Ovarian Carcinomas.Cancers (Basel)2024https://conductscience.org/library/papers/39456618PubMed
1121152119S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer.Int J Biol Sci2010https://conductscience.org/library/papers/21152119PubMed
1222276153Differential gene expression between African American and European American colorectal cancer patients.PLoS One2012https://conductscience.org/library/papers/22276153PubMed
1325193871Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).Blood2014https://conductscience.org/library/papers/25193871PubMed
1431597272MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.Cells2019https://conductscience.org/library/papers/31597272PubMed
1529945573Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.BMC Cancer2018https://conductscience.org/library/papers/29945573PubMed
1625613900Proteomics. Tissue-based map of the human proteome.Science2015https://conductscience.org/library/papers/25613900PubMed
1740721005Transforming the "cold" tumors to "hot" tumors: strategies for immune activation.Biochem Pharmacol2025https://conductscience.org/library/papers/40721005PubMed
1825962426Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response.BMC Cancer2015https://conductscience.org/library/papers/25962426PubMed
1926508480Targeting epigenetic regulations in cancer.Acta Biochim Biophys Sin (Shanghai)2016https://conductscience.org/library/papers/26508480PubMed
2029751559Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.Cancers (Basel)2018https://conductscience.org/library/papers/29751559PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
41001838Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer.J Cell Mol Med2025https://conductscience.org/library/papers/41001838

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
TRNT151095PubTator's text mininghttps://conductscience.org/library/genes/51095NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41001838

GET https://conductscience.org/api/papers/v1/41001838/references?page=2